FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESUL

VANCOUVER, BC, Aug. 15, 2023 /CNW/ - Filament Health Corp. , a clinical-stage natural psychedelic drug development company, released its first quarter financial results and operational highlights...
-Today at 07:26 am- MarketScreener

Related Keywords

Nagoya , Aichi , Japan , Vancouver , British Columbia , Canada , San Francisco , California , United States , Gabon , Canadian , Benjamin Lightburn , San Francisco Translational Psychedelic Research Program , Linkedin , Nasdaq , University Of California , Filament Health , Instagram , Twitter , Filament Health Corp , Neolumina Bioscience Inc , Jupiter Acquisition Corporation , Jupiter Acquisition , Operational Highlights , Lumina Bioscience , Translational Psychedelic Research Program , Nagoya Protocol Compliant , Amended Statements , Canada Newswire , Markets ,